Proteon Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Proteon Therapeutics's estimated annual revenue is currently $3.5M per year. 0
- Proteon Therapeutics's total funding is $170.2M.
Employee Data
- 00
Proteon Therapeutics's People
| Name | Title | Email/Phone |
|---|
Proteon Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Proteon Therapeutics?
Proteon Therapeutics is a privately held biotechnology company developing novel, first-in-class pharmaceuticals to address the critical, rapidly expanding medical needs of patients with vascular diseases. The company is leveraging a unique understanding of vascular remodeling to develop a pipeline of proprietary therapeutics. Proteon Therapeutics' first drug candidate improves blood flow during vascular surgery procedures by providing rapid, permanent, and localized vasodilation.
keywords:N/A
$170.2M
Total Funding
N/A
Number of Employees
$3.5M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Proteon Therapeutics News
... C. R. Bard, Terumo Medical, LeMaitre Vascular, Getinge, Vascular Genesis, InnAVasc Medical, CryoLife, Merit Medical Systems, Proteon Therapeutics.
... C. R. Bard, Terumo Medical, LeMaitre Vascular, Getinge AB, Vascular Genesis, InnAVasc Medical, CryoLife, Merit Medical Systems, Proteon Therapeutics.
Proteon Therapeutics Inc., a Waltham, Mass.-based biopharmaceutical company developing pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases, raised $45m in Series D equity financing. This included a $25m tranche to fund the first Phase 3 clinical s ...
Featured companies: Cyntellect, Lectus Therapeutics, NeoMatrix, Nexstim, Pearl Therapeutics, Proteon Therapeutics, SupplyScape (UPDATED at 10am PT: See below.) Airway-disease specialist Pearl Therapeutics raises $15.5M — Redwood City, Calif.-based Pearl Therapeutics, a drug-formulation company ...
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 0 | N/A | $5.9M |
#2 | $36.2M | 0 | N/A | $218.5M |
#3 | $32M | 0 | N/A | N/A |
#4 | $18.9M | 0 | N/A | $244.9M |
#5 | $0.1M | 1 | -50% | N/A |